IDEXX Laboratories, Inc. (0J8P.L) Comparison with companies in other sectors?

IDEXX Laboratories, Inc. has a share price of 78.85M. You can analyze IDEXX Laboratories, Inc. (0J8P.L) competitors across different market sectors through stock heatmaps.

What are 0J8P.L's NET and operating margins?

IDEXX Laboratories, Inc. (0J8P.L) operating margin is around 0.29, and net profit margin is approximately 0.23 as of the latest reports.

In what way does 0J8P.L's earnings per share (EPS) trend reflect its financial momentum?

IDEXX Laboratories, Inc. (0J8P.L) EPS is 8.52 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for IDEXX Laboratories, Inc. is 62.61, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for IDEXX Laboratories, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for IDEXX Laboratories, Inc. like P/E which is 48.70, P/B which is 30.10, and PEG which is 37.43. Compare them with sector averages to evaluate if the stock is priced fairly.

IDEXX Laboratories, Inc.

0J8P.L•LSE

Healthcare

Medical - Equipment & Services

£533.24

£-12.13(-2.22%)

IDEXX Laboratories, Inc. (0J8P.L) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$8.52

P/E Ratio

62.61

ROE

0.57%

Net Margin

0.23%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$42.88B

Shares OutstandingTotal number of shares issued

$78.85M

Book Value/ShareNet worth per share

$17.81

Revenue/ShareAnnual revenue per share

$48.35

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$8.517

Net MarginNet income as percentage of revenue

22.76%

Operating MarginOperating income as percentage of revenue

29.19%

ROEReturn on shareholders' equity

57.35%

ROAReturn on total assets

27.85%

ROCEReturn on capital employed

55.24%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$10.30

Cash/ShareCash and equivalents per share

$2.02

FCF YieldFree cash flow as percentage of market cap

1.94%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for 0J8P.LFinancial Ratios Analysis details for 0J8P.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 0J8P.LSector Benchmarking details for 0J8P.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for IDEXX Laboratories, Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of IDEXX Laboratories, Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account IDEXX Laboratories, Inc.'s unique business strengths and challenges.

Key Financial Metrics for IDEXX Laboratories, Inc.

For IDEXX Laboratories, Inc., essential financial indicators include EPS 8.52, PE 62.61, and ROE 0.57. These key ratios reveal insights into IDEXX Laboratories, Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare IDEXX Laboratories, Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of IDEXX Laboratories, Inc.

Metrics like Net Margin 22.76% and ROA 27.85% shed light on how well IDEXX Laboratories, Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether IDEXX Laboratories, Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of IDEXX Laboratories, Inc.

Using ratios such as P/B Ratio 30.10 and PEG Ratio 37.43, investors can assess whether IDEXX Laboratories, Inc. is appropriately valued based on its financials and growth potential. These figures, combined with IDEXX Laboratories, Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for IDEXX Laboratories, Inc.

Financial health indicators, such as Debt/Equity Ratio 0.73 and Cash Flow $10.30, provide a snapshot of IDEXX Laboratories, Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like IDEXX Laboratories, Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for IDEXX Laboratories, Inc.

Investing in IDEXX Laboratories, Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at IDEXX Laboratories, Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;